Beam Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $8,466 | $7,470 | $30,067 | $14,269 |
Gross Profit | 2,928 | 7,470 | -16,969 | 8,794 |
EBITDA | -96,753 | -113,758 | -84,926 | -101,029 |
EBIT | -102,291 | -119,286 | -90,369 | -106,504 |
Net Income | -102,291 | -109,270 | -90,354 | -96,668 |
Net Change In Cash | 8,466 | 7,470 | 30,067 | 14,269 |
Free Cash Flow | -79,586 | -106,949 | -79,335 | -89,702 |
Cash | 282,132 | 527,907 | 281,967 | 230,203 |
Basic Shares | 101,995 | 87,975 | 82,824 | 82,410 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $63,518 | $377,709 | $60,920 | $51,844 |
Gross Profit | 63,518 | -59,672 | 38,343 | 35,403 |
EBITDA | -383,975 | -156,473 | -324,332 | -392,465 |
EBIT | -415,568 | -176,485 | -346,909 | -408,906 |
Net Income | -376,742 | -132,527 | -263,588 | -341,360 |
Net Change In Cash | 63,518 | 377,709 | 60,920 | 51,844 |
Cost of Revenue | 395,729 | |||
Free Cash Flow | -356,192 | -182,927 | -26,424 | -113,079 |
Cash | 281,967 | 435,895 | 232,767 | 965,647 |
Basic Shares | 82,313 | 77,151 | 70,015 | 64,227 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$1 |
2025-03-31 | -$1.24 |
2024-12-31 | -$1.09 |
